GlassScriptPhysician profile
Garrett D Pohlman
NPI 1437378171
$122,606.02
in general payments reported to CMS, 2019-2025
42 companies · $54K in 2025
The $54K reported for 2025 was more than what 99% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,161 · 2020: $195 · 2021: $1,343 · 2022: $15K · 2023: $4,369 · 2024: $46K · 2025: $54K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $98K · Food and Beverage: $3,218 · Travel and Lodging: $3,062.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $98,133.02 |
| Food and Beverage | $3,217.64 |
| Travel and Lodging | $3,062.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $59,994.25 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Procept Biorobotics Corporation | $38,630.26 | 2022-2025 | Aquabeam System, Aquabeam Robotic System |
| Swan Valley Medical Incorporated | $9,702.46 | 2022 | |
| Intuitive Surgical, INC. | $4,468.87 | 2022 | |
| Olympus America INC. | $3,054.32 | 2024-2025 | Itind System |
| Telix Pharmaceuticals | $2,068.84 | 2023-2025 | Illuccix |
| Teleflex LLC | $1,364.54 | 2021-2025 | Urolift, Barrigel |
| Neotract INC. | $868.87 | 2019-2020 | |
| Verity Pharmaceuticals INC. | $207.17 | 2023-2025 | Trelstar |
| Abbvie INC. | $175.01 | 2019-2025 | |
| Janssen Biotech, INC. | $164.64 | 2019-2023 | Erleada |
| Boston Scientific Corporation | $150.03 | 2021-2025 | General - Female Sui, Spaceoar Vue System - 10ml, Rezum Generator |
| Bioprotect Medical, INC. | $141.20 | 2025 | Bioprotect Balloon Implant System |
| Astellas Pharma US INC | $124.00 | 2019-2025 | Xtandi |
| Dendreon Pharmaceuticals LLC | $112.45 | 2021-2025 | Provenge |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $112.41 | 2024-2025 | |
| Pfizer INC. | $107.78 | 2019-2023 | |
| Urogen Pharma, INC. | $103.17 | 2024-2025 | |
| Allergan, INC. | $89.39 | 2019-2020 | |
| Kerecis Limited | $78.87 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Medtronic USA, INC. | $68.25 | 2019 | |
| Edap Technomed INC | $64.83 | 2024-2025 | |
| Innovation Technologies INC | $61.96 | 2022-2025 | Irrisept |
| Endo Pharmaceuticals INC. | $57.86 | 2019-2023 | Xiaflex, Aveed, Edex |
| Merck Sharp & Dohme LLC | $57.39 | 2024-2025 | Keytruda |
| Myovant Sciences INC. | $56.07 | 2021-2022 | |
| Tolmar, INC. | $49.63 | 2023-2025 | Eligard |
| Becton, Dickinson and Company | $48.80 | 2023 | Bard Urinary Drainage Bag |
| Coloplast Corp | $45.26 | 2021-2024 | |
| Axonics, INC. | $41.98 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $39.18 | 2023-2024 | |
| Karl Storz Endoscopy-America | $38.86 | 2020 | |
| Amgen INC. | $38.31 | 2020-2023 | Xgeva |
| Calyxo, INC. | $36.65 | 2025 | Cvac Aspiration System |
| Tolmar Pharmaceuticals, INC. | $30.83 | 2019 | |
| Angiodynamics, INC. | $30.53 | 2023 | Nanoknife |
| Cardinal Health 414 LLC | $27.50 | 2025 | |
| Medtronic, INC. | $19.61 | 2024 | Interstim |
| Janssen Scientific Affairs, LLC | $19.38 | 2019 | |
| Conmed Corporation | $18.56 | 2019 | |
| Rochester Medical Corporation | $18.31 | 2021 | |
| Myriad Genetic Laboratories, INC. | $17.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$0.05 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Garrett Pohlman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.